Skip to main content

Proehl Gerald T's Form 4 filing

Dermata Therapeutics, Inc. (DRMA) · filed Aug 17, 2021

Accession no.
0000905718-21-001094
Filed
Aug 17, 2021
Trade date
Aug 16-17, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions and 11 derivative transactions. Open-market purchases total $49.6K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Proehl Gerald TCIK 0001279191Director, Officer (President, CEO and Chairman), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 16, 2021Common StockPPurchaseAcquired+10,000$4.96+$49,60010,000Indirect
Aug 17, 2021Common StockCConversionAcquired+17,857––17,857Indirect
Aug 17, 2021Common StockCConversionAcquired+8,928––8,928Indirect
Aug 17, 2021Common StockCConversionAcquired+35,767––35,767Indirect
Aug 17, 2021Common StockCConversionAcquired+361,147––1,278,464Indirect
Aug 17, 2021Common StockCConversionAcquired+111,951––1,390,415Indirect
Aug 17, 2021Common StockCConversionAcquired+181,585––1,572,000Indirect
Aug 17, 2021Common StockCConversionAcquired+1,247,904––2,819,904Indirect
Aug 17, 2021Common StockCConversionAcquired+85,640––2,905,544Indirect
Aug 17, 2021Common StockPPurchaseAcquired+142,857––152,857Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 17, 2021Common StockCConversionDisposed−17,857$0.00$00Indirect
Aug 17, 2021Common StockCConversionDisposed−8,928$0.00$00Indirect
Aug 17, 2021Common StockCConversionDisposed−35,767$0.00$00Indirect
Aug 17, 2021Common StockCConversionDisposed−361,147$0.00$00Indirect
Aug 17, 2021Common StockCConversionDisposed−111,951$0.00$00Indirect
Aug 17, 2021Common StockCConversionDisposed−181,585$0.00$00Indirect
Aug 17, 2021Common StockCConversionDisposed−1,247,904$0.00$00Indirect
Aug 17, 2021Common StockCConversionDisposed−85,640$0.00$00Indirect
Aug 17, 2021Common StockCConversionDisposed−27,987$0.00$00Indirect
Aug 17, 2021Common StockCConversionAcquired+27,987$0.00$027,987Indirect
Aug 17, 2021Common StockPPurchaseAcquired+142,857––142,857Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)